Hongmin Li

ORCID: 0009-0006-1955-4769 · 2 papers in corpus · active 2019-2021

Study types

  • article 2
article 2021
·doi:10.3389/fmed.2021.615195

, stanozolol may exhibit an advantage in improving erythropoiesis, while danazol may induce stronger effects on platelets. Both danazol and stanozolol exhibited immunosuppressive roles. Stanozolol could enhance the secretion of erythropoiet…

article 2019
·doi:10.1182/blood-2019-126318

Background: Stanozolol and danazol are widely used in the treatment of aplastic anemia (AA), however, they may have different effects on the recovery of hematopoiesis with the detail mechanism unclear. Methods: Bone marrow mononuclear cells…